Unknown

Dataset Information

0

Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.

ABSTRACT: Trichosanthin (TCS) is an RNA N-glycosidase that depurinates adenine-4324 in the conserved ?-sarcin/ricin loop (?-SRL) of rat 28 S ribosomal RNA (rRNA). TCS has only one chain, and is classified as type 1 ribosome-inactivating protein (RIP). Our structural studies revealed that TCS consists of two domains, with five conserved catalytic residues Tyr70, Tyr111, Glu160, Arg163 and Phe192 at the active cleft formed between them. We also found that the structural requirements of TCS to interact with the ribosomal stalk protein P2 C-terminal tail. The structural analyses suggest TCS attacks ribosomes by first binding to the C-terminal domain of ribosomal P protein. TCS exhibits a broad spectrum of biological and pharmacological activities including anti-tumor, anti-virus, and immune regulatory activities. This review summarizes an updated knowledge in the structural and functional studies and the mechanism of its multiple pharmacological effects.

SUBMITTER: Shi WW 

PROVIDER: S-EPMC6115768 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.

Shi Wei-Wei WW   Wong Kam-Bo KB   Shaw Pang-Chui PC  

Toxins 20180820 8

Trichosanthin (TCS) is an RNA <i>N</i>-glycosidase that depurinates adenine-4324 in the conserved α-sarcin/ricin loop (α-SRL) of rat 28 S ribosomal RNA (rRNA). TCS has only one chain, and is classified as type 1 ribosome-inactivating protein (RIP). Our structural studies revealed that TCS consists of two domains, with five conserved catalytic residues Tyr70, Tyr111, Glu160, Arg163 and Phe192 at the active cleft formed between them. We also found that the structural requirements of TCS to interac  ...[more]

Similar Datasets

Unknown A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein.
| S-EPMC8950148 | biostudies-literature
Unknown The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome.
| S-EPMC2632931 | biostudies-literature
Unknown Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses.
| S-EPMC1865052 | biostudies-literature
Unknown Solution structure of human P1•P2 heterodimer provides insights into the role of eukaryotic stalk in recruiting the ribosome-inactivating protein trichosanthin to the ribosome.
| S-EPMC3794596 | biostudies-literature
Unknown Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties.
| S-EPMC7150887 | biostudies-literature
Unknown Structural and functional characterization of the cytotoxic protein ledodin, an atypical ribosome-inactivating protein from shiitake mushroom (Lentinula edodes).
| S-EPMC10044108 | biostudies-literature
Unknown The Structural Characterization and Antipathogenic Activities of Quinoin, a Type 1 Ribosome-Inactivating Protein from Quinoa Seeds.
| S-EPMC8396469 | biostudies-literature
Unknown An unusual type I ribosome-inactivating protein from Agrostemma githago L.
| S-EPMC7506001 | biostudies-literature
Unknown Structural insights into the interaction of the ribosomal P stalk protein P2 with a type II ribosome-inactivating protein ricin.
| S-EPMC5122897 | biostudies-literature
Unknown A switch-on mechanism to activate maize ribosome-inactivating protein for targeting HIV-infected cells.
| S-EPMC2965250 | biostudies-literature